Highlights:

➢  Comprehensive focus on _____+ global life sciences companies that have made _____+ presentations at ___+ medical society conferences during the year 2016
➢  Analyzes ___+ medical/scientific associations that have organized conferences during the year 2016
➢  Identifies most active 100 companies presenting at multiple medical society conferences 
➢  Analyzes the life sciences companies’ presentations available on company websites
➢  Provides weekly and monthly share price analysis of global life sciences companies presenting actively versus those presenting less actively and not presenting at medical society conferences
➢  Lists the ___+ key medical society conferences covered

Key features:

➢  Comprehensive analysis of trends of presenters, organizers and contents presented
➢  Compares stock market performance of companies presenting actively versus those presenting less actively and not presenting
➢  Most useful for investors, mutual funds managers, corporate executives, business schools, trade associations and regulatory agencies involved with the global life sciences sector 

Table of Contents:

Introduction

1.1: By region (Africa/Middle East, Americas, Asia and Europe)
1.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
1.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
1.4: By frequency of presentations
1.5: By conference organizers
1.6: By research and development levels as percentage of sales (very high, high, average and low)

Section 2. Analysis of ___+ conferences organizers

2.1: By companies presenting and sub-industry
2.2: By companies presenting and key countries

Section 3. Most active 100 global life sciences companies presenting at medical society conferences

3.1: By region, country and company
3.2: By sub-industry, country and company
3.3: By market capitalization, country and company

Quarterly stock price return analysis for companies actively presented versus those presented less actively and not presented during the year 2016

4.1: By region (Africa/Middle East, Americas, Asia and Europe)
4.2: By life sciences sector sub-industries (Pharmaceuticals, Biotech, Medical Devices and Health Services)
4.3: By market capitalization (BigCap, MidCap, SmallCap and MicroCap)
4.4: By frequency of presentations
4.5: By conference organizers
4.6: By research and development levels as percentage of sales (very high, high, average and low)

5.1: For global life sciences companies
5.2: For conference organizers: Medical/scientific community
5.3: For investors
5.4: For general users (suppliers to healthcare, medical community researchers, regulators etc)

Appendices

A.1: By name
A.2: By date of conference
A.3: By country and city where held

B.1: By region, country, and company
B.2: By sub-industry, country, and company
B.3: By market capitalization, country, and company
B.4: By conference organizers, country, and company